A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel
- Status
- WITHDRAWN
- Phase
- PHASE2
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
- Status
- WITHDRAWN
- Phase
- PHASE2
Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC
- Status
- TERMINATED
- Phase
- PHASE2
Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
- Status
- TERMINATED
- Phase
- PHASE2
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemoradiation Treatment for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2